Long-Term Beta-Blocker Use After Heart Attack Doesn’t Improve Heart Health

Translate to Spanish or other 102 languages!

Using beta-blockers for an extended period of time did not improve cardiovascular health or reduce the risk of additional heart attacks, according to a study published in the journal Heart. Image for illustration purposes
Using beta-blockers for an extended period of time did not improve cardiovascular health or reduce the risk of additional heart attacks, according to a study published in the journal Heart. Image for illustration purposes

Medical News Today

- Advertisement -
  • Beta-blockers are used to treat heart problems and high blood pressure and are commonly prescribed to people following a heart attack.
  • In a new study, researchers say long-term use of the medications following a heart attack doesn’t appear to improve cardiovascular health.
  • Experts say the observational study provides valuable information, but they note that beta-blockers are still beneficial for many people.

Using beta-blockers for an extended period of time did not improve cardiovascular health or reduce the risk of additional heart attacks, according to a study published in the journal Heart.

Follow the link below to read the full story on Medical News Today:

https://www.medicalnewstoday.com/articles/study-questions-long-term-beta-blocker-use-to-curb-further-heart-attack-risk?utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2023-05-04&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS and Prominence Health Team Up on Medication Safety

 The Senior Living Seminar offered practical tips on managing prescriptions, avoiding harmful drug interactions and improving overall health outcomes.

Texas Oncology to Host Breast Cancer Awareness Symposium in McAllen on Oct. 16th

The Breast Cancer Awareness Symposium 2026 is an educational and networking event hosted by Texas Oncology and sponsored by Caris Life Sciences, bringing together oncology specialists, surgeons, advanced practice providers, and community healthcare professionals to discuss the latest advances in breast cancer prevention, diagnosis, treatment, survivorship, and reconstruction. The symposium's theme, "Breast Cancer 2026: Early Detection, Modern Care, and Survivorship Through Community Partnership," highlights the importance of multidisciplinary collaboration and patient-centered care

FDA Approves First Heart Valve Designed to Grow with Children

The U.S. Food and Drug Administration today approved the Autus Size-Adjustable Valve, a surgically implanted pulmonary heart valve for pediatric patients with congenital pulmonary valve disease.

DHR Health Offers Mammogram Screening Special During “Breast Cancer Awareness Month”

October is “Breast Cancer Awareness Month,” and DHR Health is encouraging women to prioritize their breast health by offering their annual mammogram screening special.
- Advertisement -